- Making the business case that true end-to-end integration and alignment should begin with the molecule, product, process, and technical development work that will feed into the manufacturing and supply chain operations
- Highlighting examples where including innovative technical solutions in the larger technical operations planning and execution to create more value for patients and society
- Offering ways to break down silos and allow broader collaborations internally and externally
Tongtong Wang
Senior Vice President, Global Head Technical Development
Roche
Tongtong joined Genentech in 2018 as the head of Pharmaceutical Technical Development for US Biologics, and was named global head of Pharma Technical Development in April 2021. Prior to her role at Genentech, Tongtong held several scientific, managerial and strategic roles at Eli Lilly, with increasing responsibilities in the Bioproduct Research and Development organisation. Tongtong also worked at Corixa Corporation, a biotech company, where she gained valuable experiences both as a discovery scientist and as a CMC leader in support of therapeutic antibody and cancer vaccine platforms.
Tongtong received her B. Sc. in Molecular Biology from University of Science and Technology of China, a doctorate in Biology from Syracuse University, and completed her postdoctoral training in cell biology and yeast genetics at Cornell University.
